How DOCTOLIB is trying to establish itself in one of Europe’s most tightly locked markets
📩 To contact the editorial team: editorial@startup-in-europe.com
With the acquisition of Medicus Health, Doctolib is not merely expanding its European footprint into a fifth market. The French group is above all entering the United Kingdom, one of the most complex and tightly locked healthcare software environments in Europe for general practitioners, historically dominated for more than two decades by a deeply entrenched quasi-duopoly.
The United Kingdom represents a unique case within the European digital health landscape. The General Practitioner system, which forms the backbone of British primary care, relies on software infrastructures that are deeply embedded within the operations of NHS England. The software used by medical practices does far more than manage appointments or patient records. It orchestrates prescriptions, reimbursements, medical data exchanges, administrative workflows and virtually all interactions with health authorities.
In this context, incumbent positions are extremely difficult to displace. Two players overwhelmingly dominate the market: Optum, the subsidiary of American giant UnitedHealth Group, and TPP. Their longstanding presence provides them with a considerable structural advantage through deep technical integration, regulatory expertise, user inertia and the operational dependency of medical practices.
And it is precisely this barrier that Doctolib is now attempting to bypass. The central element of the transaction lies in the approval obtained by Medicus from the NHS in June 2025. This certification is far more than a simple regulatory validation. It represents the essential gateway into the British primary care market. Without it, entering the market would likely have required several years of development, integration work and technical negotiations.
By acquiring Medicus, Doctolib is therefore purchasing less a twenty-person startup than a strategic position within the NHS software ecosystem. The acquisition aligns with the group’s broader evolution as it increasingly seeks to become a comprehensive software provider for healthcare professionals.
The company now develops practice management tools, patient record systems, billing solutions, electronic transmission systems, consultation assistants and telephony tools, to which it is now adding artificial intelligence capabilities designed to automate certain administrative and clinical tasks.
The United Kingdom is therefore becoming a strategic laboratory for Doctolib, with the group announcing plans to invest more than £100 million over the coming years, notably through the opening of a research and development center dedicated to primary care and the recruitment of 150 employees.
The acquisition also comes at a particularly difficult moment for the NHS. The British healthcare system is facing growing pressure linked to shortages of general practitioners, overloaded medical practices, rising administrative burdens and an ageing population. In this environment, automation is gradually becoming a structural necessity to preserve the operational capacity of primary care.
The deal also reflects a broader transformation within the European healthtech sector. After a decade dominated by medical marketplaces and teleconsultation platforms, competition is now shifting toward the invisible layers of healthcare organization: professional software systems, clinical workflows, administrative automation and medical data infrastructure.
